NHS needs to ramp up non-emergency treatments by 10% to tackle pandemic backlog

Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.

Eli Lilly to acquire Morphic for $3.2 billion

Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to

July 8, 2024

AstraZeneca subsidiary to sell its Bangalore site, to hunt for external manufacturer

AstraZeneca’s India subsidiary is selling its only manufacturing site in Bangalore as part of an ongoing strategic review of its manufacturing and supply network, according

November 18, 2023

John Maraganore on his new biotech venture, R&D vivacity and Nobel award-winning AI

It’s been two years since Alnylam’s founding CEO John Maraganore announced he was stepping back from the company. And in that time, he’s built up

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.